Acetylcholine receptor antibodies ACHR

It looks like you’re asking about acetylcholine receptor (AChR) antibodies in detail. These antibodies are primarily associated with myasthenia gravis (MG), an autoimmune neuromuscular disorder. Here’s a breakdown of what you need to know:

Types of AChR Antibodies

1. Binding Antibodies (Most Common)

   • Found in about 85% of generalized MG cases.
   • They bind to ACh receptors at the neuromuscular junction, leading to receptor degradation.

2. Blocking Antibodies

   • Prevent acetylcholine from binding to its receptor, reducing signal transmission.
   • Less commonly tested but can contribute to MG symptoms.

3. Modulating Antibodies

   • Cause internalization and destruction of ACh receptors.
   • Detected in some patients who have MG but are seronegative for binding antibodies.

Role in Myasthenia Gravis

• These antibodies attack acetylcholine receptors at the neuromuscular junction.
• Leads to muscle weakness and fatigue, which worsens with activity.
• Common symptoms: ptosis (drooping eyelids), difficulty swallowing, limb weakness, respiratory issues.

Diagnosis

• AChR antibody test: Measures levels of binding, blocking, or modulating antibodies.
• Other tests:
  • MuSK (Muscle-Specific Kinase) Antibodies: If AChR antibodies are negative.
  • Electromyography (EMG) and Tensilon Test for neuromuscular function.
  • CT/MRI: To check for a thymoma (tumor in the thymus gland).

Treatment Options

• Acetylcholinesterase inhibitors (e.g., pyridostigmine) to boost acetylcholine levels.
• Corticosteroids & Immunosuppressants to reduce autoimmune activity.
• Plasmapheresis/IVIG for severe cases.
• Thymectomy (if a thymoma is present).